Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FeelGood vs PauseRX

FeelGood
Graded #127

Higher grade

vs+1
PauseRX
Graded #150

Lower grade

The verdict

FeelGood takes it — 69.5/100 to 68.5/100, but only just.

FeelGood grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight-loss program offering compounded GLP-1 medications (weekly injections and daily dissolvable tablets) plus limited brand-name options, prescribed by US-licensed providers and shipped to… PauseRX is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFeelGood +14
80
66
Dose & formulationPauseRX +21
64
85
Clinical oversightPauseRX +4
79
83
Labs & monitoringFeelGood +1
53
52
FulfillmentFeelGood +10
71
61
Contract termsFeelGood +14
55
41
FeelGood · left barPauseRX · right bar

The numbers

MetricFeelGoodPauseRX
WeighScore69.5/10068.5/100
GradeCC
Scorecard rank#127#150
SemaglutideNot disclosed$199/mo
TirzepatideNot disclosed$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
FeelGood

Graded #127 · C

Strengths

  • Both compounded semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) formulations available
  • Low compounded injection entry price ($149/mo) with no membership or hidden fees
  • Oral/dissolvable tablet option for needle-averse patients
  • LegitScript-certified site (seal #247923); OpenLoop Health telehealth backbone
  • Free shipping and HSA/FSA eligibility

Where it loses points

  • State availability not publicly disclosed on the site
  • Compounding pharmacy partner not named publicly ("US-certified pharmacy" only)
  • Brand-name ("Original") injections are expensive at $1,999/mo and limited in availability
PauseRX

Graded #150 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard